The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human phase 1 PET study of CTT1057, a novel 18F-labeled imaging agent targeting prostate specific membrane antigen (PSMA) in prostate cancer.
 
Rahul Raj Aggarwal
No Relationships to Disclose
 
Spencer Behr
Research Funding - Cancer Targeted Technology
 
Youngho Seo
No Relationships to Disclose
 
Kenneth Gao
No Relationships to Disclose
 
Vahid Rahanfar
No Relationships to Disclose
 
Jim Slater
No Relationships to Disclose
 
Joseph Blecha
No Relationships to Disclose
 
Beatrice Langton-Webster
Employment - Cancer Targeted Technology
Leadership - Cancer Targeted Technology
Stock and Other Ownership Interests - Cancer Targeted Technology
Patents, Royalties, Other Intellectual Property - Cancer Targeted Technology
 
Clifford Berkman
No Relationships to Disclose
 
Henry Vanbrocklin
No Relationships to Disclose